The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients

被引:2
作者
Braga-Diniz, Julia Mourao [1 ]
Santa-Rosa, Caroline Christine [1 ]
Martins, Renata de Castro [2 ]
Souza e Silva, Maria Elisa [1 ]
Vieira, Leda Quercia [3 ]
Ribeiro Sobrinho, Antonio Paulino [1 ]
机构
[1] Univ Fed Minas Gerais, Sch Dent, Dept Operat Dent, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil
来源
BRAZILIAN ORAL RESEARCH | 2017年 / 31卷
关键词
Immunosuppression; Hematopoietic stem cell transplantation; Endodontics; DNA-DNA HYBRIDIZATION; MARROW-TRANSPLANTATION; GLOBAL PERSPECTIVE; INFECTIONS; MICROBIOTA; LEUKEMIA; RECIPIENTS; BACTERIA; DISEASE; BLOOD;
D O I
10.1590/1807-3107BOR-2017.vol31.0050
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this study is to investigate the relationship between the epidemiological and clinical profiles of patients before and after hematopoietic stem cell transplantation (HSCT) and the need for endodontic treatment. The subjects included 188 individuals enrolled in the dental care program for transplanted patients of the School of Dentistry, Federal University of Minas Gerais (Faculdade de Odontologia da Universidade Federal de Minas Gerais, FO-UFMG) from March 2011 through March 2016. The patients were subjected to an HSCT conditioning dental regimen based on a thorough clinical and radiographic evaluation. Intraoral periapical and bite-wing X-rays were obtained, and after evaluation, specific dental treatment was planned and performed. The following demographic and clinical data were collected from the patients' medical records: age, gender, transplantation stage, primary disease, transplant type, medication used, complete blood count at the time of visit, and need for endodontic treatment. The Kolmogorov-Smirnov and the chi-square tests were used. Leukemia (31.3%) and multiple myeloma (17.9%) were the most prevalent primary diseases. Most patients were subjected to allogeneic-related transplantation (83.6%). Most patients exhibited platelet counts and hemoglobin concentrations below the reference values in the pre-transplantation stage, while the neutrophil and platelet counts and the hemoglobin levels were within the reference ranges in the post-transplantation stage. The proportions of individuals requiring endodontic treatment were similar between the pre-and post-transplantation groups: 24.3% and 24.7%, respectively. The systemic conditions of the patients referred for dental treatment were compromised.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Hematopoietic Stem Cell Transplantation for Leukemia
    Wayne, Alan S.
    Baird, Kristin
    Egeler, R. Maarten
    PEDIATRIC CLINICS OF NORTH AMERICA, 2010, 57 (01) : 1 - +
  • [32] Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation
    Jordan, Karina
    Pontoppidan, Peter
    Uhlving, Hilde H.
    Kielsen, Katrine
    Burrin, Douglas G.
    Weischendorff, Sarah
    Christensen, Ib J.
    Jorgensen, Marianne H.
    Heilmann, Carsten
    Sengelov, Henrik
    Muller, Klaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1170 - 1176
  • [33] Donor-Derived Solid Malignancies after Hematopoietic Stem Cell Transplantation
    Hu, Yong-xian
    Cui, Qu
    Liang, Bin
    Huang, He
    ONKOLOGIE, 2010, 33 (04): : 195 - 200
  • [34] Hematopoietic stem cell transplantation in the treatment of autoimmune diseases
    Kozák, T
    WIENER KLINISCHE WOCHENSCHRIFT, 2002, 114 (1-2) : 7 - 13
  • [35] Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation
    Nygaard, M.
    Hovgaard, D.
    Schjodt, I. M.
    Andersen, N. S.
    Vindelov, L.
    Sengelov, H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 358 - 361
  • [36] Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
    Atkins, Harold L.
    Freedman, Mark S.
    NEUROTHERAPEUTICS, 2017, 14 (04) : 888 - 893
  • [37] Successful Transplantation of Kidney Allografts in Sensitized Rats After Syngeneic Hematopoietic Stem Cell Transplantation and Fludarabine
    Fu, Y.
    Sun, Z.
    Fuchs, E. J.
    Wang, Y.
    Shen, Z. -Y.
    Maeda, H.
    Lin, Q.
    Warren, D. S.
    Williams, G. M.
    Montgomery, R. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (10) : 2375 - 2383
  • [38] Skin Biopsy in Pediatric Oncology/Hematopoietic Stem Cell Transplantation Patients
    Bui, Justin
    Harvey, Nathan T.
    Berry, Bligh
    Chan, Jonathan
    Ramachandran, Shanti
    Gough, Hazel
    Wood, Benjamin A.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2022, 44 (10) : 728 - 733
  • [39] Oral management of adult patients undergoing hematopoietic stem cell transplantation
    Bollero, P.
    Passarelli, P. C.
    D'Addona, A.
    Pasquantonio, G.
    Mancini, M.
    Condo, R.
    Cerroni, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (04) : 876 - 887
  • [40] Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation
    Mishra, Asmita
    Anasetti, Claudio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S49 - S52